Volume | 2,497 |
|
|||||
News | - | ||||||
Day High | 17.5068 | Low High |
|||||
Day Low | 17.31 |
Company Name | Etf Ticker Symbol | Market | Type |
---|---|---|---|
ProShares UltraShort NASDAQ Biotechnology | BIS | NASDAQ | Exchange Traded Fund |
Open Price | Low Price | High Price | Close Price | Prev Close |
---|---|---|---|---|
17.38 | 17.31 | 17.5068 | 17.58 | 17.44 |
Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
---|---|---|---|---|---|
34 | 2,497 | 17.45 | 43,585 | - | 16.37 - 26.51 |
Last Trade Time | Type | Quantity | Etf Price | Currency |
---|---|---|---|---|
16:00:00 | 200 | 17.5068 | USD |
ProShares UltraShort NASDAQ Biotechnology Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
4.31M | 246.00k | - | 99k | -3.51M | -14.27 | - |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
News ProShares UltraShort NAS...
Loading Messages....
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
BIS Historical
Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 17.53 | 17.96 | 17.31 | 17.70 | 15,636 | 0.05 | 0.29% |
1 Month | 16.75 | 18.43 | 16.75 | 17.70 | 7,823 | 0.83 | 4.96% |
3 Months | 17.65 | 18.82 | 16.37 | 17.58 | 25,761 | -0.07 | -0.40% |
6 Months | 22.02 | 26.51 | 16.37 | 18.62 | 14,537 | -4.44 | -20.16% |
1 Year | 21.06 | 26.51 | 16.37 | 19.03 | 9,400 | -3.48 | -16.52% |
3 Years | 23.18 | 35.64 | 15.86 | 22.33 | 17,245 | -5.60 | -24.16% |
5 Years | 17.54 | 36.49 | 6.9501 | 16.40 | 57,871 | 0.04 | 0.23% |
The investment seeks daily investment results that correspond to two times the inverse (-2x) of the daily performance of the Nasdaq Biotechnology Index. The fund invests in financial instruments that ProShare Advisors believes, in combination, should produce daily returns consistent with the funds investment objective. The index is a modified capitalization weighted index that includes securities of Nasdaq listed companies that are classified as either biotechnology or pharmaceutical. The fund is non-diversified. |